Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk

Author(s):  Cabaleiro Joe

Issue:  Jan/Feb 2020 - Volume 24, Number 1
View All Articles in Issue

Page(s):  21-27

Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 1
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 2
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 3
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 4
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 5
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 6
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Page 7

Download in electronic PDF format for $75

Abstract:  United States Pharmacopeia Chapter <800>, which became effective on December 1, 2019, addresses handling of hazardous drugs in facilities that make compounded preparations. The Chapter includes minimum facility, engineering controls, personal protective equipment, and other requirements under which all hazardous drugs must be handled. For certain hazardous drugs, an assessment of risk may be performed to determine alternative containment strategies or work practices. This article addresses the legal enforceability of Unites States Pharmacopeia Chapter <800>, how to determine whether a drug is eligible for an assessment of risk, and details important considerations when performing assessments of risk.

Related Keywords: Joe Cabaleiro, RPh, United States Pharmacopeia Chapter <800>, USP, risk assessment, hazardous drugs, engineering controls, drug exposures, enforcement, antineoplastic drugs, reproductive hazardous drugs, NIOSH, OSHA, handling requirements, standard operating procedure, SOP

Related Categories: BUSINESS, LEGAL, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS, PROFESSIONAL ISSUES, HAZARDOUS DRUGS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk
Cabaleiro Joe
Jan/Feb 2020
Pg. 21-27

PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
Sep/Oct 2021
Pg. 356

PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
Mar/Apr 2020
Pg. 92

PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
May/Jun 2020
Pg. 180

PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
May/Jun 2017
Pg. 180

Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
Mar/Apr 2021
Pg. 115-124

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2007
Pg. 404-410

PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 92

Change Is In the Air: What You Need to Know About Pharmacy Ventilation Under United States Pharmacopeia <800>
Laniewicz Cheryl
Jul/Aug 2017
Pg. 271-274

Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
Mar/Apr 2012
Pg. 146-150

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr
, Okeke Claudia C
Jan/Feb 2009
Pg. 56-62

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
Sep/Oct 2018
Pg. 401-404

A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
Mar/Apr 2014
Pg. 94-99

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests
Kupiec Thomas C
Sep/Oct 2007
Pg. 400-403

Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
Jul/Aug 2007
Pg. 302-305

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2008
Pg. 136-144

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2008
Pg. 252-257

Return to Top